Promino Nutritional Sciences Inc.
MUSL
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4,288.24% | 1,057.32% | 14.36% | -38.45% | -90.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4,288.24% | 1,057.32% | 14.36% | -38.45% | -90.33% |
| Cost of Revenue | 1,379.06% | 38,300.00% | -44.94% | -91.79% | -55.58% |
| Gross Profit | 953.77% | 319.38% | 51.01% | 107.75% | -123.61% |
| SG&A Expenses | -69.66% | -76.46% | -130.05% | 294.65% | 207.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -57.21% | -71.43% | -111.43% | 5,787.26% | 191.28% |
| Operating Income | 73.81% | 79.22% | 113.91% | -857.84% | -227.74% |
| Income Before Tax | 52.41% | 83.32% | 104.30% | -1,086.15% | -155.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 52.41% | 83.32% | 104.30% | -1,086.15% | -155.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.41% | 83.32% | 104.30% | -1,086.15% | -155.82% |
| EBIT | 73.81% | 79.22% | 113.91% | -857.84% | -227.74% |
| EBITDA | -- | -- | 114.07% | -837.16% | -229.27% |
| EPS Basic | 77.20% | 92.43% | 101.57% | -1,225.00% | -49.03% |
| Normalized Basic EPS | 78.13% | 92.42% | 100.39% | -1,314.29% | -48.84% |
| EPS Diluted | 77.20% | 92.43% | 101.57% | -1,225.00% | -49.03% |
| Normalized Diluted EPS | 78.13% | 92.42% | 100.39% | -1,314.29% | -48.84% |
| Average Basic Shares Outstanding | 109.84% | 123.88% | 173.76% | -12.99% | 71.62% |
| Average Diluted Shares Outstanding | 109.84% | 123.88% | 173.76% | -12.99% | 71.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |